We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Continued Need for Placebo in Many Cases, Even When There Is Effective Therapy

Robert J. Temple, MD; Robert Meyer, MD
Arch Intern Med. 2003;163(3):371. doi:10.1001/archinte.163.3.371-a.
Text Size: A A A
Published online


In a recent commentary,1 Miller and Shorr discuss generally the use of placebo controls when there is an existing effective treatment and then consider specifically 3 recent placebo-controlled studies in asthma, all of which they believe did not need to use a placebo. In at least 1 of the 3 studies, the issue is more complex than they allow.

The authors note the recent increased interest in the ethics of the use of placebo controls provoked by the 2000 revision of the Declaration of Helsinki,2 which said such controls were not appropriate when there was existing effective therapy. Miller and Shorr clearly recognize, however, the interpretive problems often posed by active control equivalence or noninferiority trials35 and thus the continued need for placebo controls in many situations, even when there is existing therapy. Indeed, a commentary on the 2000 revision by the World Medical Association in 20016 indicates similar recognition, so long as use of the placebo instead of available therapy does not expose patients to serious harm. Miller and Shorr divide placebo considerations into the following 3 categories: (1) when failure to use available therapy exposes patients to risk of death, irreversible harm, or intolerable discomfort (placebo is clearly unacceptable in such cases); (2) when the condition causes only mild to moderate discomfort (headache, allergic rhinitis, and/or heartburn) and patients frequently forgo treatment (there is no ethical impediment to use of placebo in such cases); (3) when the illnesses are more serious and discomfort associated with nontreatment is more severe, but methodological considerations call for use of a placebo and the study is designed to minimize discomfort. It is into this last category that the authors place asthma, along with angina, migraine headaches, and depression. Although studies of those conditions require attention to patient selection and study design (in case of worsening), that should not lead to the conclusion that placebo controls are not needed in those cases.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Distributions of Test Results Illustrate the Spectrum Problem

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed